Evaluation of the Atlas Genetics io® CTNG System
Condition(s):Chlamydia Trachomatis; GonorrheaLast Updated:April 3, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Chlamydia Trachomatis; GonorrheaLast Updated:April 3, 2020Completed
Condition(s):Uterine Fibroids; Heavy Menstrual BleedingLast Updated:March 5, 2021Completed
Condition(s):Heart Disease CongenitalLast Updated:August 13, 2020Completed
Condition(s):MelanomaLast Updated:September 20, 2021Completed
Condition(s):Type 2 Diabetes MellitusLast Updated:May 11, 2021Completed
Condition(s):Heart Failure With Preserved Ejection FractionLast Updated:October 11, 2021Completed
Condition(s):Mitral Valve Insufficiency; Coronary Artery DiseaseLast Updated:June 29, 2023Active, not recruiting
Condition(s):Mucocutaneous Lymph Node SyndromeLast Updated:December 3, 2021Completed
Condition(s):Peripheral Artery Disease; Atherosclerosis; Artery Diseases, Peripheral; Plaque, Atherosclerotic; Occlusive Arterial DiseaseLast Updated:March 26, 2024Completed
Condition(s):Sickle Cell Disease; Thalassemia; Diamond-Blackfan AnemiaLast Updated:September 23, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.